Latest in Cardiology from ACC.org

• Treatment Effect of M-TEER in COAPT Trial vs. Real-World Practice | NCDR Study
  Estimated treatment effects of mitral transcatheter edge-to-edge repair (M-TEER) in COAPT trial participants and real-world patients from the STS/ACC TVT Registry were similar, according to a recent study published in JACC.
• High Pediatric Ablation Success Regardless of Center and Operator Volume | NCDR Study
  Acute ablation success in pediatric patients was high across a range of center and operator volumes, with high-volume sites demonstrating the greatest likelihood of success for complex substrates, according to a recent study published in JACC: Advances.
• ACC Scientific Statement Addresses Cognitive Impairment, Frailty in Patients With CV Disease
  With older adults rarely experiencing cardiovascular disease in isolation, ACC's newest Scientific Statement on "Cognitive Impairment and Frailty in Older Adults With Cardiovascular Disease" stresses the importance of considering cognitive impairment, frailty and physical disability within the context of cardiovascular decision-making.
• ACC CardiaCast: Risk Assessment and Genetics in the Prevention of Cardiovascular Disease
  This episode of CardiaCast will feature a discussion on risk assessment and genetics in the prevention of cardiovascular disease.
• In Memoriam: ACC Past President Robert L. Frye, MD, MACC
  The ACC mourns the loss of Robert L. Frye, MD, MACC, a distinguished physician, investigator, educator and leader whose career helped shape modern cardiovascular medicine, as well as the College. Frye, who served as ACC President from 1991-1992, leaves behind a legacy of service to patients and the profession spanning more than seven decades.